Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Samiha Jaddaoui"'
Autor:
Samiha Jaddaoui, Hanaa Bencharef, Sara Addakiri, Hind Dehbi, Amal Tazzite, Mouna Lamchahab, Bouchra Oukkache
Publikováno v:
Annales de Biologie Clinique. 81:136-144
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e3d0653436c9c4d1e6afded476ebd7d
https://doi.org/10.1684/abc.2023.1798
https://doi.org/10.1684/abc.2023.1798
Publikováno v:
Clinical laboratory. 68(10)
Aberrant phenotypes in acute myeloid leukemia have variable frequencies and their prognostic value with adverse hematological and other biological prognostic factors is still controversial, despite several reports of clinical significance. To date, n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a3df62e498531e67c93ef7e193ad64d
https://pubmed.ncbi.nlm.nih.gov/36250828
https://pubmed.ncbi.nlm.nih.gov/36250828
Autor:
Samiha Jaddaoui, Hanaa Bencharef, Sara Addakiri, Hind Dehbi, Mouna Lamchahab, Asmaa Quessar, Abdellah Madani, Bouchra Oukkache
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S255-S256
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f87b194a1e5ca89becd2781a15dcc68
https://doi.org/10.1016/s2152-2650(22)01304-0
https://doi.org/10.1016/s2152-2650(22)01304-0
Publikováno v:
Clinical Laboratory. 68
Leukemia stem cells (LSCs) have been demonstrated to be more therapy-resistant than leukemic blast cells reflecting measurable residual disease (MRD). CD34+CD38- cell frequency is an independent factor for relapse prediction and could therefore be us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::410b0a47b86c90bb515f26205ab2150c
https://doi.org/10.7754/clin.lab.2021.210821
https://doi.org/10.7754/clin.lab.2021.210821
Autor:
Hanaa Bencharef, Asmaa Koudouss, Samiha Jaddaoui, Dounia Dassouli, Abdellah Madani, Meryem Qachouh, Bouchra Oukkache
Publikováno v:
Annales de biologie clinique. 79(6)
Large granular lymphocyte leukemia (LGL) constitutes a heterogeneous entity with very different immunophenotypic, clonal and evolutionary characteristics. The most common LGL-T are CD3 +, CD8 +, CD16 +, CD57 +, CD56-. The majority of patients have a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe23359950e8bf82a86ffd5a35a5ddc1
https://pubmed.ncbi.nlm.nih.gov/34961740
https://pubmed.ncbi.nlm.nih.gov/34961740
Autor:
Samiha Jaddaoui, Hanaa Bencharef, Sara Addakiri, Hind Dehbi, Mouna Lamchahab, Asmaa Quessar, Abdellah Madani, Bouchra Oukkache
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S136
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a7339bbe4023ad3954336d5cadbdf66
https://doi.org/10.1016/s2152-2650(22)00821-7
https://doi.org/10.1016/s2152-2650(22)00821-7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.